Table 3 Demographic and clinical characteristics of the study subjects according to sex-specific tertiles of FIB

Age (years)

56.4 ± 11.1

55.5 ± 9.6

56.9 ± 10.0

0.731

55.08 ± 11.8

59.6 ± 8.4

63.3 ± 9.3

0.001

BMI (kg/m²)

25.5 ± 2.9

26.4 ± 3.6

26.7 ± 4.5

0.140

23.6 ± 3.5

24.4 ± 3.4

25.6 ± 2.8

0.029

Hypertension, n (%)

38 (55.1%)

42 (61.8%)

47 (69.1%)

0.238

15 (36.6%)

21 (50.0%)

30 (73.2%)

0.004

Diabetes, n (%)

16 (23.2%)

21 (30.9%)

19 (27.9%)

0.594

7 (17.1%)

10 (23.8%)

9 (22.0%)

0.739

Dyslipidemia, n (%)

56 (81.2%)

51 (75.0%)

57 (83.8%)

0.419

23 (56.1%)

26 (61.9%)

34 (82.9%)

0.025

TC (mmol/L)

4.32 ± 1.15

4.63 ± 0.99

4.49 ± 1.20

0.272

5.03 ± 1.96

5.02 ± 1.03

4.91 ± 1.30

0.916

TG (mmol/L)

1.48 (1.00, 2.13)

1.83 (1.37, 2.49)

1.44 (1.06, 2.08)

0.012

1.46 (0.85, 2.15)

1.50 (1.05, 2.55)

1.61 (1.17, 2.16)

0.463

HDL-C (mmol/L)

1.13 ± 0.31

1.06 ± 0.27

1.09 ± 0.27

0.316

1.33 ± 0.39

1.31 ± 0.32

1.19 ± 0.32

0.132

LDL-C (mmol/L)

2.58 ± 0.95

2.81 ± 0.85

2.76 ± 0.98

0.323

2.89 ± 0.80

3.06 ± 0.80

2.99 ± 1.00

0.682

hsCRP (mg/L)

0.72 (0.47, 1.11)

1.68 (0.85, 3.04)

2.4 (1.33, 3.04)

< 0.001

0.79 (0.40, 1.51)

1.12 (0.74, 1.85)

3.01 (1.66, 5.16)

< 0.001

NP

12 (17.4%)

14 (20.6%)

13 (19.1%)

0.892

21 (51.2%)

11 (26.2%)

8 (19.5%)

0.005

CP

25 (36.3%)

29 (42.6%)

20 (29.4%)

0.275

15 (36.6%)

20 (47.6%)

11 (26.8%)

0.146

NCP/MP

32 (46.4%)

25 (36.8%)

35 (51.5%)

0.216

5 (12.2%)

11 (26.2%)

22 (53.7%)

< 0.001